Changes in Mortality During the COVID-19 Pandemic in Japan: Descriptive Analysis of National Health Statistics up to 2022
Journal of Epidemiology · 2025
DOI: 10.2188/jea.je20240158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Epidemiology, 2025. Verfasst von Hirokazu Tanaka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Population Data Science, National Cancer Center Institute for Cancer Control. Hauptthemen laut MEDLINE: COVID-19, Mortality. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Cancer Control Policy from the Ministry of Health, Labour, and Welfare, Japan, PRESTO from the Japan Science and Technology Agency.
Abstract (Originalsprache)
BACKGROUND: Amidst the global coronavirus disease 2019 (COVID-19) pandemic, Japan has faced a significant public health challenge, evident from the significant increase in mortality rates since 2021. This study described the variations in all-cause and cause-specific changes in mortality up to 2022 in Japan. METHODS: This study used official Vital Statistics from the Ministry of Health, Labour and Welfare (MHLW) to assess the impact of the pandemic on mortality trends. An analysis of all-cause and cause-specific age-standardized mortality rates (ASMRs) from 1995 to 2022 was conducted, employing the 2015 Japan Standard Population. Sex- and cause-specific ASMRs for a particular year were compared with those from the preceding year to assess annual changes. RESULTS: Among men, the annual all-cause ASMR per 100,000 people increased from 1,356.3 in 2021 to 1,437.8 in 2022 (6.0% increase). Among women, the annual all-cause ASMR increased from 722.1 in 2021 to 785.8 in 2022 (6.5% increase). Compared with the period 2020 to 2021, COVID-19 (+29.1 per 100,000 people for men and +13.4 per 100,000 people for women), senility (+14.1 per 100,000 people for men and +12.5 per 100,000 people for women), heart disease, malignant neoplasms (for women) and "other causes not classified as major causes" substantially contributed to the increase in all-cause ASMR from 2021 to 2022. CONCLUSION: Further long-term monitoring from 2023 onwards is necessary, especially for conditions like senility, cardiovascular disease, and cancer, which may have long-term effects due to changes in healthcare settings, even though the strong countermeasures against COVID-19 were lifted in 2023.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Population Data Science, National Cancer Center Institute for Cancer Control.
- Keio University Global Research Institute (KGRI).
- Department of Health Policy and Management, School of Medicine, Keio University.
- Division of Prevention, National Cancer Center Institute for Cancer Control.
ORCID-Profile: Hirokazu Tanaka, Shuhei Nomura, Kota Katanoda
Förderung
- Cancer Control Policy from the Ministry of Health, Labour, and Welfare, Japan
- PRESTO from the Japan Science and Technology Agency
Zitieren
APA
Tanaka, H., Nomura, S., & Katanoda, K. (2025). Changes in Mortality During the COVID-19 Pandemic in Japan: Descriptive Analysis of National Health Statistics up to 2022. Journal of Epidemiology. https://doi.org/10.2188/jea.je20240158
Vancouver
Tanaka H, Nomura S, Katanoda K. Changes in Mortality During the COVID-19 Pandemic in Japan: Descriptive Analysis of National Health Statistics up to 2022. Journal of Epidemiology. 2025. doi:10.2188/jea.je20240158
BibTeX
@article{Tanaka2025,
author = {Tanaka, Hirokazu and Nomura, Shuhei and Katanoda, Kota},
title = {Changes in Mortality During the COVID-19 Pandemic in Japan: Descriptive Analysis of National Health Statistics up to 2022},
journal = {Journal of Epidemiology},
year = {2025},
doi = {10.2188/jea.je20240158}
}
EUVIMED